Skip to main content
. 2019 Sep 11;12(18):2931. doi: 10.3390/ma12182931

Figure 6.

Figure 6

Expression of Runx2 in the u-HA/PLLA and PLLA groups. (A–F): In the u-HA/PLLA group, Runx2 expression decreased significantly from weeks 2 to 8. (G–L): Runx2 expression in the PLLA group was generally lower, except in specimens with new bone. (A,C,E): Images of the u-HA/PLLA-treated samples taken at 4× magnification at weeks 2, 4, and 8, respectively. (G,I,K): Images of PLLA-treated samples taken at 4× magnification at weeks 2, 4, and 8, respectively. (B,D,F,H,J,L): Images of the boxed regions in (A,C,E,G,I,K), respectively, at 20× magnification.